Compare Stocks: BDMD, APYX, CNXU, and ECOR

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
APYX Apyx Medical	$2.96	$3.33	$1.89 ▼ $5.08	$124.68M	1.31	88,294 shs	131,399 shs
BDMD Baird Medical Investment	$0.77	$1.08	$0.66 ▼ $3.70	$32.35M	-1.15	61,591 shs	50,012 shs
CNXU Conexeu Sciences	$3.89	$6.96	$3.82 ▼ $18.79	$109.74M	N/A	208,091 shs	111,197 shs
ECOR electroCore	$11.12	$8.96	$4.41 ▼ $12.70	$100.30M	1	82,233 shs	52,223 shs

10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
APYX Apyx Medical	0.00%	-3.27%	-3.90%	-36.89%	+46.53%
BDMD Baird Medical Investment	0.00%	-27.00%	-31.56%	-32.76%	-66.08%
CNXU Conexeu Sciences	0.00%	-21.57%	-44.98%	-62.01%	+388,999,900.00%
ECOR electroCore	0.00%	-4.79%	+15.47%	+36.95%	+125.56%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
APYX Apyx Medical	$2.96	$3.33	$1.89 ▼ $5.08	$124.68M	1.31	88,294 shs	131,399 shs
BDMD Baird Medical Investment	$0.77	$1.08	$0.66 ▼ $3.70	$32.35M	-1.15	61,591 shs	50,012 shs
CNXU Conexeu Sciences	$3.89	$6.96	$3.82 ▼ $18.79	$109.74M	N/A	208,091 shs	111,197 shs
ECOR electroCore	$11.12	$8.96	$4.41 ▼ $12.70	$100.30M	1	82,233 shs	52,223 shs

10 Stocks Powering The Next AI Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
APYX Apyx Medical	0.00%	-3.27%	-3.90%	-36.89%	+46.53%
BDMD Baird Medical Investment	0.00%	-27.00%	-31.56%	-32.76%	-66.08%
CNXU Conexeu Sciences	0.00%	-21.57%	-44.98%	-62.01%	+388,999,900.00%
ECOR electroCore	0.00%	-4.79%	+15.47%	+36.95%	+125.56%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
APYX Apyx Medical	2.71	Moderate Buy	$6.60	122.97% Upside
BDMD Baird Medical Investment	1.00	Sell	N/A	N/A
CNXU Conexeu Sciences	2.00	Hold	$20.00	414.14% Upside
ECOR electroCore	2.00	Hold	$18.00	61.87% Upside

Current Analyst Ratings Breakdown

Latest BDMD, APYX, CNXU, and ECOR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/21/2026	APYX Apyx Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
9/21/2026	ECOR electroCore	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
8/17/2026	CNXU Conexeu Sciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Sell (E-)
8/5/2026	BDMD Baird Medical Investment	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
7/14/2026	APYX Apyx Medical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold
7/13/2026	APYX Apyx Medical	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$7.00
6/29/2026	CNXU Conexeu Sciences	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold

(Data available from 9/28/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
APYX Apyx Medical	$52.84M	2.36	N/A	N/A	$0.39 per share	7.59
BDMD Baird Medical Investment	$22.54M	1.44	N/A	N/A	N/A	∞
CNXU Conexeu Sciences	N/A	N/A	N/A	N/A	N/A	N/A
ECOR electroCore	$32.03M	3.13	N/A	N/A	($0.21) per share	-52.95

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
APYX Apyx Medical	-$11.21M	-$0.20	N/A	N/A	N/A	-14.78%	-76.60%	-13.91%	11/5/2026 (Estimated)
BDMD Baird Medical Investment	N/A	N/A	N/A	5.48	N/A	N/A	N/A	N/A	N/A
CNXU Conexeu Sciences	-$3.92M	-$0.40	N/A	N/A	N/A	N/A	-200.20%	-177.26%	N/A
ECOR electroCore	-$13.97M	-$1.66	N/A	N/A	N/A	-39.96%	-1,956.38%	-81.35%	11/4/2026 (Estimated)

Latest BDMD, APYX, CNXU, and ECOR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/14/2026	Q3 2026	CNXU Conexeu Sciences	-$0.10	-$0.29	-$0.19	-$0.29	N/A	N/A
8/6/2026	Q2 2026	APYX Apyx Medical	-$0.0820	-$0.07	+$0.0120	-$0.07	$13.18 million	$13.88 million
8/6/2026	Q2 2026	ECOR electroCore	-$0.4218	-$0.33	+$0.0918	-$0.33	$9.49 million	$9.45 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
APYX Apyx Medical	N/A	N/A	N/A	N/A	N/A
BDMD Baird Medical Investment	N/A	N/A	N/A	N/A	N/A
CNXU Conexeu Sciences	N/A	N/A	N/A	N/A	N/A
ECOR electroCore	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
APYX Apyx Medical	3.19	5.68	4.53
BDMD Baird Medical Investment	N/A	N/A	N/A
CNXU Conexeu Sciences	N/A	5.31	5.31
ECOR electroCore	N/A	1.21	1.00

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
APYX Apyx Medical	55.33%
BDMD Baird Medical Investment	19.78%
CNXU Conexeu Sciences	N/A
ECOR electroCore	26.74%

Insider Ownership

Company	Insider Ownership
APYX Apyx Medical	15.90%
BDMD Baird Medical Investment	78.90%
CNXU Conexeu Sciences	N/A
ECOR electroCore	7.80%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
APYX Apyx Medical	205	42.12 million	35.43 million	Optionable
BDMD Baird Medical Investment	146	42.21 million	8.91 million	N/A
CNXU Conexeu Sciences	4	28.21 million	N/A	N/A
ECOR electroCore	83	9.02 million	8.31 million	Not Optionable

BDMD, APYX, CNXU, and ECOR Headlines

Recent News About These Companies

electroCore Has A Line Of Sight At Cash Breakeven

September 26 at 9:00 AM | seekingalpha.com

electroCore (NASDAQ:ECOR) Director Purchases $49,100.00 in Stock

September 25 at 4:53 AM | americanbankingnews.com

Head-To-Head Survey: Anteris Technologies Global (NASDAQ:AVR) and electroCore (NASDAQ:ECOR)

September 24, 2026 | americanbankingnews.com

Thomas Errico Purchases 5,000 Shares of electroCore (NASDAQ:ECOR) Stock

September 23, 2026 | insidertrades.com

Thomas Errico Buys 5,000 Shares of electroCore (NASDAQ:ECOR) Stock

September 22, 2026 | marketbeat.com

electroCore (ECOR) Stock Jumps 6.9%: Will It Continue to Soar?

September 18, 2026 | zacks.com

electroCore (NASDAQ:ECOR) Trading 3% Higher - What's Next?

September 15, 2026 | marketbeat.com

electroCore to Participate at H.C. Wainwright Global Investment Conference

September 10, 2026 | globenewswire.com

ElectroCore appoints Joshua Lev and Mike Fox as co-CEOs

September 9, 2026 | msn.com

electroCore, Inc. Appoints Joshua Lev and Mike Fox as Co-Chief Executive Officers

September 9, 2026 | globenewswire.com

electroCore (NASDAQ:ECOR) CFO Joshua Lev Sells 3,000 Shares

August 26, 2026 | insidertrades.com

electroCore’s Truvaga® Named Best Luxury Biohacking & Longevity Brand in the USA by Luxury Lifestyle Awards

August 25, 2026 | markets.businessinsider.com

electroCore's Truvaga® Named Best Luxury Biohacking & Longevity Brand in the USA by Luxury Lifestyle Awards

August 25, 2026 | globenewswire.com

electroCore (NASDAQ:ECOR) Director Thomas Errico Acquires 5,000 Shares

August 18, 2026 | insidertrades.com

electroCore Announces Second Quarter 2026 Financial Results

August 7, 2026 | markets.businessinsider.com

electroCore, Inc. (ECOR) Q2 2026 Earnings Call Transcript

August 6, 2026 | seekingalpha.com

electroCore, Inc. (ECOR) Reports Q2 Loss, Tops Revenue Estimates

August 6, 2026 | zacks.com

electroCore to Participate in Upcoming Investor Conferences

August 3, 2026 | globenewswire.com

electroCore to Announce Second Quarter June 30, 2026, Financial Results on Thursday, August 6, 2026

July 30, 2026 | globenewswire.com

Ecora Royalties reports 61% jump in strong quarter

July 29, 2026 | proactiveinvestors.co.uk

New Review Examines Anatomical and Methodological Differences Between Auricular and Cervical Vagus Nerve Stimulation

July 16, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

BDMD, APYX, CNXU, and ECOR Company Descriptions

Apyx Medical NASDAQ:APYX

$2.96 0.00 (0.00%)

Closing price 09/25/2026 04:00 PM Eastern

Extended Trading

$2.89 -0.07 (-2.23%)

As of 09/25/2026 07:34 PM Eastern

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Baird Medical Investment NASDAQ:BDMD

$0.77 0.00 (0.00%)

Closing price 09/25/2026 04:00 PM Eastern

Extended Trading

$0.78 +0.01 (+1.63%)

As of 09/25/2026 07:27 PM Eastern

Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.

Conexeu Sciences NASDAQ:CNXU

$3.89 0.00 (0.00%)

Closing price 09/25/2026 04:00 PM Eastern

Extended Trading

$3.86 -0.03 (-0.77%)

As of 09/25/2026 07:30 PM Eastern

Conexeu is a company focused on building a new class of collagen-based regenerative tissue products. The Company was incorporated on November 2, 2022 under the Business Corporations Act (British Columbia) and was continued out of British Columbia and domesticated into the State of Nevada under the laws of the State of Nevada on April 10, 2025. --- Conexeu is an early-stage medical device company formed to acquire and commercialize intellectual property ("IP") developed over more than a decade at the University of British Columbia (the "University") and the BC Professional Firefighters Burn and Wound Healing Laboratory. In November 2023, the Company entered into a patent assignment agreement with the University pursuant to which the Company acquired an assignment of the University's right, title, and interest in the applicable patents and patent applications related to the underlying technology. The Company's only device candidate is the CXU™ scaffold device candidate, which is in preclinical development and has not been approved or cleared for marketing in any jurisdiction. The Company is conducting preclinical research and preparing for regulatory engagement to evaluate potential use in wound care and other medical applications. Any potential benefits to patients, providers, or healthcare systems have not been established and will require further study and regulatory review. CXU™ is a temperature-responsive, collagen-based extracellular matrix ("ECM") formulation designed to transition from a liquid to a gel-like scaffold following topical application or injection, typically within approximately ten minutes (the "10 Minute Tissue™" concept). The device IP is protected by issued and pending patents and is being evaluated in preclinical studies for its ability to provide an ECM-like environment associated with cellular infiltration, vascularization, and organized tissue remodeling in non-clinical models. We intend to seek U.S. Food and Drug Administration ("FDA") clearance in the United States for the CXU™ scaffold device candidate through the 510(k) premarket notification process as a Class II medical device; however, the FDA has not yet determined the appropriate classification or regulatory pathway for our device candidate, may require additional data or a different pathway, and there can be no assurance that we will obtain clearance or that the device candidate will become commercially available. Our principal executive offices are located in Reno, Nevada.

electroCore NASDAQ:ECOR

$11.12 0.00 (0.00%)

Closing price 09/25/2026 04:00 PM Eastern

Extended Trading

$11.12 0.00 (-0.04%)

As of 09/25/2026 07:30 PM Eastern

electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BDMD, APYX, CNXU, and ECOR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BDMD, APYX, CNXU, and ECOR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BDMD, APYX, CNXU, and ECOR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

BDMD, APYX, CNXU, and ECOR Company Descriptions

Apyx Medical NASDAQ:APYX

Baird Medical Investment NASDAQ:BDMD

Conexeu Sciences NASDAQ:CNXU

electroCore NASDAQ:ECOR

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BDMD, APYX, CNXU, and ECOR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BDMD, APYX, CNXU, and ECOR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BDMD, APYX, CNXU, and ECOR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

BDMD, APYX, CNXU, and ECOR Company Descriptions

Apyx Medical NASDAQ:APYX

Baird Medical Investment NASDAQ:BDMD

Conexeu Sciences NASDAQ:CNXU

electroCore NASDAQ:ECOR

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools